APIs
| Therapeutic Category | API | Pharmacopeia | USDMF | CEP | CDMF | KDMF | TDMF |
| Neuropsychiatric | Lacosamide | EP/USP | √ | √ | √ | Under Filling | √ |
| Vortioxetine Hydrobromide | In-House | √ | √ | Under Filling | √ | ||
| Brivaracetam | In-House | √ | √ | ||||
| Agomelatine | In-ouse | √ | |||||
| Brexpiprazole | In-House | √ | √ | ||||
| Cenobamate | In-House | Under Filling | |||||
| Anti-Cancer | Ibrutinib | In-House | √ | √ | Under Filling | ||
| Lenalidomide | In-House | √ | |||||
| Apalutamide | In-House | √ | |||||
| Relugolix | In-House | √ | |||||
| Abemaciclib | In-House | Under Filling | |||||
| Genitourinary system | Imidafenacin | In-House | √ | ||||
| Cardiovascular | Ambrisentan | In-House | √ | ||||
| Prasugrel HCl | EP/USP | ||||||
| Antifungal | Isavuconazonium sulfate | In-House | √ | √ | |||
| Others | Tigecycline | EP/USP | |||||
| Ilaprazole | In-House | Under Filling | |||||
| Finerenone | In-House | Under Filling | |||||
| Pirfenidone | EP | √ | |||||
| Minodronic Acid | In-House |
| Therapeutic Category | API |
| Anti-Cancer | Alectinib |
| Ribociclib | |
| Upadacitinib | |
| Lenvatinib |
| Therapeutic Category | API |
| Other | Baloxavir marboxil |
| Givinostat | |
| Beraprost sodium |
Disclaimer:
- This list of products and reference to any product herein should not be construed and/or constituted transaction where it is not permitted underpatent law of the country and/or
is not authorized by other laws and regulations of the country. - All the products under the patent are only for R&D use.
Beijing Hope Pharmaceutical Co., Ltd.
